1. Home
  2. Browse Decisions
  3. F.3d
  4. 875 F.3d
  5. 875 F.3d 636 (2017)
 

SANOFI v. WATSON LABORATORIES INC.

2016-2722, 2016-2726.

875 F.3d 636 (2017)

SANOFI, Sanofi-Aventis U.S., LLC, Plaintiffs-Appellees v. WATSON LABORATORIES INC., Sandoz Inc., Defendants-Appellants.

United States Court of Appeals, Federal Circuit.

Decided: November 9, 2017.

Attorney(s) appearing for the Case

WILLIAM E. SOLANDER , Fitzpatrick, Cella, Harper & Scinto, New York, NY, argued for plaintiffs-appellees. Also represented by ANNA ELIZABETH DWYER , ZACHARY GARRETT , DANIEL JOHN MINION , JAMES R. TYMINSKI, JR.

MAUREEN L. RURKA , Winston & Strawn LLP, Chicago, IL, argued for defendant-appellants. Defendant-appellant Sandoz Inc. also represented by TYLER JOHANNES , JULIA MANO JOHNSON .

NATALIE CHRISTINE CLAYTON , Alston & Bird LLP, New York, NY, for defendant-appellant Watson Laboratories, Inc. Also represented by CHRISTOPHER L. McARDLE , YI WEN WU .

Before Prost, Chief Judge, Wallach, and Taranto, Circuit Judges.

Sanofi owns U.S. Patent Nos. 8,318,800 and 8,410,167, which describe and claim compositions and uses of the cardiovascular (specifically, antiarrhythmic) drug dronedarone. The '800 patent, which expires in 2019, claims pharmaceutical compositions containing dronedarone. The '167 patent, which expires in 2029, claims methods...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases